{"id":"https://openalex.org/W7225808375","doi":"https://doi.org/10.3389/fimmu.2026.1934453","title":"Deep immune profiling of stage III resected melanoma patients undergoing anti-PD1 adjuvant therapy unveils critical immunophenotypes associated with tumor recurrence or adverse effects","display_name":"Deep immune profiling of stage III resected melanoma patients undergoing anti-PD1 adjuvant therapy unveils critical immunophenotypes associated with tumor recurrence or adverse effects","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7225808375","doi":"https://doi.org/10.3389/fimmu.2026.1934453"},"language":"en","primary_location":{"id":"doi:10.3389/fimmu.2026.1934453","doi":"https://doi.org/10.3389/fimmu.2026.1934453","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1934453","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1934453/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1934453/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5144420765","display_name":"Hugo Brouque","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210128919","display_name":"\u00c9tablissement Fran\u00e7ais du Sang","ror":"https://ror.org/037hby126","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128919"]},{"id":"https://openalex.org/I4210160510","display_name":"Institut pour l'avanc\u00e9e des biosciences","ror":"https://ror.org/05kwbf598","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2800555055","https://openalex.org/I4210128919","https://openalex.org/I4210139971","https://openalex.org/I4210150872","https://openalex.org/I4210160510","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Hugo Brouque","raw_affiliation_strings":["Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","institution_ids":["https://openalex.org/I4210128919"]},{"raw_affiliation_string":"Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210160510","https://openalex.org/I899635006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026309891","display_name":"Eleonora Sosa Cuevas","orcid":"https://orcid.org/0000-0002-2093-9707","observed_orcids":["https://orcid.org/0000-0002-2093-9707"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210128919","display_name":"\u00c9tablissement Fran\u00e7ais du Sang","ror":"https://ror.org/037hby126","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128919"]},{"id":"https://openalex.org/I4210160510","display_name":"Institut pour l'avanc\u00e9e des biosciences","ror":"https://ror.org/05kwbf598","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2800555055","https://openalex.org/I4210128919","https://openalex.org/I4210139971","https://openalex.org/I4210150872","https://openalex.org/I4210160510","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Eleonora Sosa Cuevas","raw_affiliation_strings":["Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","institution_ids":["https://openalex.org/I4210128919"]},{"raw_affiliation_string":"Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210160510","https://openalex.org/I899635006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114376117","display_name":"St\u00e9phane Mouret","orcid":"https://orcid.org/0000-0003-3880-973X","observed_orcids":["https://orcid.org/0000-0003-3880-973X"]},"institutions":[{"id":"https://openalex.org/I2800555055","display_name":"Centre Hospitalier Universitaire de Grenoble","ror":"https://ror.org/041rhpw39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2800555055"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Stephane Mouret","raw_affiliation_strings":["Univ. Grenoble Alpes, Dermatology, Allergology & Photobiology Department, CHU Grenoble Alpes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Grenoble Alpes, Dermatology, Allergology & Photobiology Department, CHU Grenoble Alpes","institution_ids":["https://openalex.org/I2800555055","https://openalex.org/I899635006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011139857","display_name":"Tania Dufeu\u2010Duchesne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210128919","display_name":"\u00c9tablissement Fran\u00e7ais du Sang","ror":"https://ror.org/037hby126","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128919"]},{"id":"https://openalex.org/I4210160510","display_name":"Institut pour l'avanc\u00e9e des biosciences","ror":"https://ror.org/05kwbf598","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2800555055","https://openalex.org/I4210128919","https://openalex.org/I4210139971","https://openalex.org/I4210150872","https://openalex.org/I4210160510","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Tania Dufeu-Duchesne","raw_affiliation_strings":["Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","institution_ids":["https://openalex.org/I4210128919"]},{"raw_affiliation_string":"Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210160510","https://openalex.org/I899635006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024491938","display_name":"Myl\u00e8ne Pezet","orcid":"https://orcid.org/0000-0002-4365-7454","observed_orcids":["https://orcid.org/0000-0002-4365-7454"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210160510","display_name":"Institut pour l'avanc\u00e9e des biosciences","ror":"https://ror.org/05kwbf598","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2800555055","https://openalex.org/I4210128919","https://openalex.org/I4210139971","https://openalex.org/I4210150872","https://openalex.org/I4210160510","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Mylene Pezet","raw_affiliation_strings":["Institute for Advanced Biosciences, Plateforme de Microscopie Photonique - Imagerie Cellulaire et Cytom\u00e9trie en Flux (Microcell), Inserm U1209 - CNRS UMR 5309, Universit\u00e9 Grenoble Alpes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute for Advanced Biosciences, Plateforme de Microscopie Photonique - Imagerie Cellulaire et Cytom\u00e9trie en Flux (Microcell), Inserm U1209 - CNRS UMR 5309, Universit\u00e9 Grenoble Alpes","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210160510","https://openalex.org/I899635006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082058511","display_name":"Julie Charles","orcid":"https://orcid.org/0000-0003-4667-6009","observed_orcids":["https://orcid.org/0000-0003-4667-6009"]},"institutions":[{"id":"https://openalex.org/I2800555055","display_name":"Centre Hospitalier Universitaire de Grenoble","ror":"https://ror.org/041rhpw39","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I2800555055"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Julie Charles","raw_affiliation_strings":["Univ. Grenoble Alpes, Dermatology, Allergology & Photobiology Department, CHU Grenoble Alpes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Univ. Grenoble Alpes, Dermatology, Allergology & Photobiology Department, CHU Grenoble Alpes","institution_ids":["https://openalex.org/I2800555055","https://openalex.org/I899635006"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5065004424","display_name":"Philippe Saas","orcid":"https://orcid.org/0000-0002-8857-9939","observed_orcids":["https://orcid.org/0000-0002-8857-9939"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210128919","display_name":"\u00c9tablissement Fran\u00e7ais du Sang","ror":"https://ror.org/037hby126","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128919"]},{"id":"https://openalex.org/I4210160510","display_name":"Institut pour l'avanc\u00e9e des biosciences","ror":"https://ror.org/05kwbf598","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2800555055","https://openalex.org/I4210128919","https://openalex.org/I4210139971","https://openalex.org/I4210150872","https://openalex.org/I4210160510","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Philippe Saas","raw_affiliation_strings":["Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","institution_ids":["https://openalex.org/I4210128919"]},{"raw_affiliation_string":"Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210160510","https://openalex.org/I899635006"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011680362","display_name":"Caroline Aspord","orcid":"https://orcid.org/0000-0002-4979-7044","observed_orcids":["https://orcid.org/0000-0002-4979-7044"]},"institutions":[{"id":"https://openalex.org/I1294671590","display_name":"Centre National de la Recherche Scientifique","ror":"https://ror.org/02feahw73","country_code":"FR","type":"government","lineage":["https://openalex.org/I1294671590"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210128919","display_name":"\u00c9tablissement Fran\u00e7ais du Sang","ror":"https://ror.org/037hby126","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210128919"]},{"id":"https://openalex.org/I4210160510","display_name":"Institut pour l'avanc\u00e9e des biosciences","ror":"https://ror.org/05kwbf598","country_code":"FR","type":"facility","lineage":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I2800555055","https://openalex.org/I4210128919","https://openalex.org/I4210139971","https://openalex.org/I4210150872","https://openalex.org/I4210160510","https://openalex.org/I899635006"]},{"id":"https://openalex.org/I899635006","display_name":"Universit\u00e9 Grenoble Alpes","ror":"https://ror.org/02rx3b187","country_code":"FR","type":"education","lineage":["https://openalex.org/I899635006"]}],"countries":["FR"],"is_corresponding":true,"raw_author_name":"Caroline Aspord","raw_affiliation_strings":["Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Etablissement Fran\u00e7ais du Sang Auvergne-Rh\u00f4ne-Alpes, R&D Laboratory","institution_ids":["https://openalex.org/I4210128919"]},{"raw_affiliation_string":"Institute for Advanced Biosciences, Team: Immunology & Immunotherapy of Chronic Diseases, Inserm U 1209, CNRS UMR 5309, Univ. Grenoble Alpes","institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210160510","https://openalex.org/I899635006"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5011680362"],"corresponding_institution_ids":["https://openalex.org/I1294671590","https://openalex.org/I154526488","https://openalex.org/I4210128919","https://openalex.org/I4210160510","https://openalex.org/I899635006"],"apc_list":{"value":3150,"currency":"CHF","value_usd":3801},"apc_paid":{"value":3150,"currency":"CHF","value_usd":3801},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"17","issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10392","display_name":"Cutaneous Melanoma Detection and Management","score":0.0008999999845400453,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8120999932289124},{"id":"https://openalex.org/C2777658100","wikidata":"https://www.wikidata.org/wiki/Q180614","display_name":"Melanoma","level":2,"score":0.6796000003814697},{"id":"https://openalex.org/C2777982462","wikidata":"https://www.wikidata.org/wiki/Q2481887","display_name":"Adjuvant therapy","level":3,"score":0.6509000062942505},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6092000007629395},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5770000219345093},{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.5741999745368958},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5658000111579895},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47699999809265137},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4431999921798706},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.4334999918937683},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.4287000000476837},{"id":"https://openalex.org/C196166836","wikidata":"https://www.wikidata.org/wiki/Q902926","display_name":"Immunophenotyping","level":3,"score":0.40849998593330383},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.34459999203681946},{"id":"https://openalex.org/C2781188995","wikidata":"https://www.wikidata.org/wiki/Q6934982","display_name":"Multiplex","level":2,"score":0.334199994802475},{"id":"https://openalex.org/C63363279","wikidata":"https://www.wikidata.org/wiki/Q5133848","display_name":"Clinical significance","level":2,"score":0.3260999917984009},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.31769999861717224},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.3140999972820282},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.30649998784065247},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.30000001192092896},{"id":"https://openalex.org/C2780057760","wikidata":"https://www.wikidata.org/wiki/Q13896859","display_name":"Pembrolizumab","level":4,"score":0.2996000051498413},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.29589998722076416},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.27079999446868896},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.260699987411499},{"id":"https://openalex.org/C2776999253","wikidata":"https://www.wikidata.org/wiki/Q1304270","display_name":"Combination therapy","level":2,"score":0.25839999318122864}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.3389/fimmu.2026.1934453","doi":"https://doi.org/10.3389/fimmu.2026.1934453","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1934453","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1934453/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.3389/fimmu.2026.1934453","doi":"https://doi.org/10.3389/fimmu.2026.1934453","is_oa":true,"landing_page_url":"https://doi.org/10.3389/fimmu.2026.1934453","pdf_url":"https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2026.1934453/pdf","source":{"id":"https://openalex.org/S2595292759","display_name":"Frontiers in Immunology","issn_l":"1664-3224","issn":["1664-3224"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320527","host_organization_name":"Frontiers Media","host_organization_lineage":["https://openalex.org/P4310320527"],"host_organization_lineage_names":["Frontiers Media"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Frontiers in Immunology","raw_type":"journal-article"},"sustainable_development_goals":[],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7225808375.pdf","grobid_xml":"https://content.openalex.org/works/W7225808375.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W1963964693","https://openalex.org/W2039123767","https://openalex.org/W2129503578","https://openalex.org/W2238034263","https://openalex.org/W2341604280","https://openalex.org/W2560285379","https://openalex.org/W2578510022","https://openalex.org/W2613155517","https://openalex.org/W2615907969","https://openalex.org/W2752227448","https://openalex.org/W2755857262","https://openalex.org/W2757936530","https://openalex.org/W2766903152","https://openalex.org/W2772791962","https://openalex.org/W2783417222","https://openalex.org/W2797309423","https://openalex.org/W2809714481","https://openalex.org/W2939305168","https://openalex.org/W2957955537","https://openalex.org/W2963476376","https://openalex.org/W3031842572","https://openalex.org/W3090469545","https://openalex.org/W3109864685","https://openalex.org/W3122401323","https://openalex.org/W3146935595","https://openalex.org/W3153178523","https://openalex.org/W3153228158","https://openalex.org/W3165102087","https://openalex.org/W3170122536","https://openalex.org/W3184800171","https://openalex.org/W3197265554","https://openalex.org/W3200550458","https://openalex.org/W3213529109","https://openalex.org/W4220979904","https://openalex.org/W4288096597","https://openalex.org/W4307208617","https://openalex.org/W4321018001","https://openalex.org/W4321376446","https://openalex.org/W4363675163","https://openalex.org/W4377108024","https://openalex.org/W4381597723","https://openalex.org/W4385481273","https://openalex.org/W4387492255","https://openalex.org/W4388895609","https://openalex.org/W4391773766","https://openalex.org/W4392104059","https://openalex.org/W4392542906","https://openalex.org/W4401321992","https://openalex.org/W4404937298","https://openalex.org/W4406856294","https://openalex.org/W4408761409","https://openalex.org/W4409561054","https://openalex.org/W4410876040","https://openalex.org/W4412199902","https://openalex.org/W7118170147","https://openalex.org/W7131629759","https://openalex.org/W7134137061","https://openalex.org/W7172313785"],"related_works":[],"abstract_inverted_index":{"Introduction":[0],"Immune":[1,129],"checkpoint":[2],"blockers":[3],"(ICB)":[4],"are":[5],"standard":[6],"of":[7,33,36,44,73,93,165,192,198],"care":[8],"as":[9,157,159],"adjuvant":[10,82,223],"therapy":[11,83],"for":[12],"patients":[13,20,78,156,219],"with":[14,80,88,105,124,163,167,174,183,210],"resected":[15,74],"high-risk":[16],"melanoma,":[17],"yet":[18],"many":[19],"suffer":[21],"from":[22],"immune-related":[23],"adverse":[24],"effects":[25],"(AEs),":[26],"while":[27,234],"others":[28],"experienced":[29],"tumor":[30,38,89,211],"relapse.":[31],"Identification":[32],"biomarkers":[34],"capable":[35],"predicting":[37],"relapse":[39],"or":[40,213],"understanding":[41],"the":[42,63],"occurrence":[43,92,164],"AEs":[45,214],"remains":[46],"a":[47,96],"major":[48],"challenge":[49],"to":[50,230,242],"improve":[51],"outcomes":[52],"and":[53,56,68,84,91,112,115,120,138,152,170,188,194,202,237],"develop":[54],"efficient":[55],"more":[57],"tolerated":[58],"strategies.":[59],"Methods":[60],"We":[61,144,177,205],"explored":[62],"immune":[64,147,160],"landscape":[65,148],"at":[66],"baseline":[67],"during":[69],"treatment":[70],"in":[71,127,215,247],"blood":[72],"stage":[75,216],"III":[76,217],"melanoma":[77,155,218],"treated":[79,220],"anti-PD-1":[81],"evaluated":[85],"its":[86],"association":[87],"recurrence":[90,212],"AEs.":[94],"Through":[95],"comprehensive":[97],"immunomonitoring":[98],"based":[99],"on":[100],"multi-parametric":[101],"flow":[102],"cytometry":[103],"combined":[104],"multiplex":[106],"immunoassays,":[107],"we":[108],"depicted":[109],"DC,":[110],"monocyte,":[111],"effector":[113],"subsets":[114],"examined":[116],"their":[117],"detailed":[118],"phenotypic":[119],"functional":[121,175],"features":[122,130],"together":[123,173],"soluble":[125],"factors":[126],"plasma.":[128],"were":[131],"compared":[132],"between":[133,149],"groups":[134],"using":[135],"both":[136],"supervised":[137],"unsupervised":[139],"computational":[140],"machine-learning":[141],"analyses.":[142],"Results":[143],"revealed":[145],"distinct":[146],"non-relapsing":[150],"(NP)":[151],"progressive":[153],"(PD)":[154],"well":[158],"profiles":[161],"associated":[162,182,209],"AEs,":[166,236],"modulated":[168],"innate":[169],"adaptive":[171],"immunophenotypes":[172,208],"perturbations.":[176],"highlighted":[178],"innovative":[179],"predictive":[180],"signatures":[181],"clinical":[184,245],"outcome:":[185],"plasmatic":[186],"ULBP3/4":[187],"CD73":[189],"levels,":[190],"importance":[191],"DC3":[193],"monocyte":[195],"subsets,":[196],"relevance":[197],"new":[199],"checkpoints":[200],"(Gal9/TIM3":[201],"CD155/TIGIT).":[203],"Discussion":[204],"uncovered":[206],"candidate":[207],"by":[221],"anti-PD1":[222],"therapy.":[224],"Deciphering":[225],"such":[226],"challenges":[227],"is":[228],"promising":[229],"optimize":[231],"ICB":[232],"efficacy":[233],"reducing":[235],"design":[238],"pertinent":[239],"combination":[240],"strategies":[241],"achieve":[243],"better":[244],"successes":[246],"future.":[248]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-11-12T00:00:00"}